Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.75 HKD | -1.04% | -4.23% | -27.48% |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
Strengths
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- The company's attractive earnings multiples are brought to light by a P/E ratio at 10.11 for the current year.
- The stock, which is currently worth 2023 to 0.48 times its sales, is clearly overvalued in comparison with peers.
- The company's share price in relation to its net book value makes it look relatively cheap.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
- The group usually releases upbeat results with huge surprise rates.
Weaknesses
- The company's earnings growth outlook lacks momentum and is a weakness.
- Revenue estimates are regularly revised downwards for the current and coming years.
- For the last four months, EPS estimates made by Standard & Poor's analysts have been revised downwards.
- Over the past four months, analysts' average price target has been revised downwards significantly.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Pharmaceuticals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-27.48% | 785M | B- | ||
+37.15% | 6.12B | B- | ||
-16.04% | 4.44B | C+ | ||
-11.16% | 3.14B | B- | ||
-1.40% | 3.03B | C | ||
+0.12% | 2.57B | - | D+ | |
+38.69% | 1.87B | - | ||
+1.11% | 1.63B | - | - | |
-10.34% | 1.62B | - | - | |
-12.97% | 1.53B | C- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- 1666 Stock
- Ratings Tong Ren Tang Technologies Co. Ltd.